AG490

AG490 has been studied in 6 papers since 2017: 1 observational study in people, 3 in animals, 2 in cells. It has not reached trials in people. The newest paper, Feb 25, 2025: “Occurrence of cellular senescence in chronic human shoulder tendinopathies and its attenuation ex vivo by inhibition of Enhancer of Zeste 2”.

InterventionPreclinical

6 papers study it7 more mention it11 findingsUpdated

PubChemChEBI

See all 13 papers on AG490

At a glance

The findings reach people, from one lab or study; independent labs found the same change in cells. 6 independent labs in 2 countries.

“similarly to the senotherapeutic compound AG490”
Occurrence of cellular senescence in chronic human shoulder tendinopathies and its attenuation ex vivo by inhibition of Enhancer of Zeste 2Bone & joint research2025doi:10.1302/2046-3758.142.bjr-2023-0378.r2

None of its findings points the other way.

Cells: replicated by independent labs. Mice and humans: a single group. Worms or flies: nothing yet.
  • 6 independent labs in 2 countries
  • Funders: National Natural Science Foundation of China and others
  • 1 of 11 findings with company ties
  • Humans1
  • Animals3
  • Cells2

What did studies of AG490 find?

8

Studies of AG490 measured 8 outcomes; the most studied is cellular senescence (4 studies).

Cellular senescence

downin human cells2downin cells1downin mice1

4 studies
  1. AG490 decreases cellular senescence in liver fibrotic factor-treated UC-MSCs.

    “elevated senescence-associated secretory phenotype (SASP) and senescence in UC-MSCs and could be reversed by a specific JAK inhibitor AG490.”

    Cellsin liver fibrotic factor-treated UC-MSCs

    Administration of AG490 decreases the senescence of umbilical cord-mesenchymal stem cells and promotes the cytotherapeutic effect in liver fibrosis

    Cell death discovery

  2. AG490 decreases cellular senescence in ischemic stroke mice.

    “AG490 treatment reduced oxidative DNA damage and cellular senescence in the brains of mice following ischemic stroke.”

    Animalsin ischemic stroke micebrain

    Targeting the JAK2-STAT3 pathway to inhibit cGAS-STING activation improves neuronal senescence after ischemic stroke

    Experimental neurology

  3. AG490 decreases cellular senescence in cells (aged TSPCs; senescence and SASP).

    “Pharmacological inhibition of JAK-STAT signaling pathway with AG490 similarly attenuated cellular senescence and senescence-associated secretory phenotype (SASP) of aged TSPCs”

    Cellsaged TSPCs; senescence and SASPtendon

    Inhibition of JAK-STAT Signaling Pathway Alleviates Age-Related Phenotypes in Tendon Stem/Progenitor Cells

    Frontiers in cell and developmental biology

  4. AG490 decreases cellular senescence in BM-MSCs from SLE patients.

    “AG490, the inhibitor of JAK2, and knockdown of STAT3 in BM-MSCs, could significantly reverse the senescence.”

    Cellsin BM-MSCs from SLE patientsbone marrow

    JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients

    Acta biochimica et biophysica Sinica

More on Cellular senescence

Senescence-associated secretory phenotype (SASP)

downin humans1

1 study
  1. AG490 decreases senescence-associated secretory phenotype (SASP) in humans (ex vivo tendon biopsies).

    “similarly to the senotherapeutic compound AG490”

    Human trialex vivo tendon biopsiestendon

    Occurrence of cellular senescence in chronic human shoulder tendinopathies and its attenuation ex vivo by inhibition of Enhancer of Zeste 2

    Bone & joint research

More on Senescence-associated secretory phenotype (SASP)

Cartilage endplate degeneration

downin rats1

1 study
  1. AG490 decreases cartilage endplate degeneration in rats.

    “the in vivo experiment results confirmed that the JAK2/STAT3 pathway inhibitor AG490 significantly reversed these effects.”

    Animals

    LTF ameliorates cartilage endplate degeneration by suppressing calcification, senescence and matrix degradation through the JAK2/STAT3 pathway

    Journal of cellular and molecular medicine

cGAS–STING signaling

downin mice1

1 study
  1. AG490 inhibits cGAS–STING signaling in ischemic stroke mice.

    “AG490 blocked cGAS/STING/NF-κBp65 expression.”

    Animalsin ischemic stroke micebrain

    Targeting the JAK2-STAT3 pathway to inhibit cGAS-STING activation improves neuronal senescence after ischemic stroke

    Experimental neurology

More on cGAS–STING signaling

Inflammation

downin mice1

1 study
  1. AG490 decreases inflammation in ischemic stroke mice.

    “reduced expression of pro-inflammatory cytokines, and decreased activation of pro-inflammatory microglia”

    Animalsin ischemic stroke micebrain

    Targeting the JAK2-STAT3 pathway to inhibit cGAS-STING activation improves neuronal senescence after ischemic stroke

    Experimental neurology

More on Inflammation

Neurobehavioral defects

downin mice1

1 study
  1. AG490 decreases neurobehavioral defects in ischemic stroke mice.

    “alleviated neurobehavioral defects”

    Animalsin ischemic stroke mice

    Targeting the JAK2-STAT3 pathway to inhibit cGAS-STING activation improves neuronal senescence after ischemic stroke

    Experimental neurology

Brain infarct volume

downin mice1

1 study
  1. AG490 decreases brain infarct volume in ischemic stroke mice.

    “alleviated neurobehavioral defects, reduced brain infarct volume”

    Animalsin ischemic stroke micebrain

    Targeting the JAK2-STAT3 pathway to inhibit cGAS-STING activation improves neuronal senescence after ischemic stroke

    Experimental neurology

Self-renewal, migration, actin dynamics and stemness

upin cells1

1 study
  1. AG490 improves self-renewal, migration, actin dynamics and stemness in cells (aged TSPCs; via JAK-STAT pathway inhibition).

    “inhibition of JAK-STAT signaling pathway also restored the age-related dysfunctions of TSPCs, including self-renewal, migration, actin dynamics, and stemness”

    Cellsaged TSPCs; via JAK-STAT pathway inhibitiontendon

    Inhibition of JAK-STAT Signaling Pathway Alleviates Age-Related Phenotypes in Tendon Stem/Progenitor Cells

    Frontiers in cell and developmental biology

Latest

See all 13 papers on AG490